TCL Archive Komen Officials Say Charity is Stabilizing Despite 22 Percent Drop in Contributions January 24, 2014
TCL Archive Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time April 16, 1999
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
